id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-327360-4qpk99x9	Elsawah, Hozaifa Khalil	Hydroxychloroquine for treatment of non‐severe COVID‐19 patients; systematic review and meta‐analysis of controlled clinical trials	2020-08-18		.txt	text/plain	3182	211	49	The objectives are to summarize efficacy of HCQ use in COVID-19 relative to control based on available clinical trials indicated by all possible improvements of the disease This article is protected by copyright. There are three types of variables; 1) independent variable is HCQ therapy, 2) dependent variables include viral clearance in the pharyngeal swab, clinical progression (increase in the baseline severity), radiological progression, adverse effects, and mortality, 3) confounders include usual treatment that varied among studies, age, sex, disease onset, and different HCQ doses. The present meta-analysis targeted non-severe COVID-19 patients to assess the efficacy and safety of HCQ based on the available evidence. No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial Hydroxychloroquine for COVID-19: A review and a debate based on available clinical trials/case studies	./cache/cord-327360-4qpk99x9.txt	./txt/cord-327360-4qpk99x9.txt